Glucosamine Prices

Glucosamine Prices September 2024

The glucosamine prices in the United States for Q3 2024 reached 7480 USD/MT in September. The main hub of market activity was the US. Price levels indicated a slight increase and stayed constant. The market environment this quarter was well-balanced, which went against the trend from the previous quarter. A balanced interaction between industry factors and more general economic indicators is reflected in this market stability.

The price trend for glucosamine in China for Q3 2024 reached 5580 USD/MT in September. China's market continued to perform steadily from quarter to quarter, solidifying its standing as a benchmark for regional price. As a result of both local consumption dynamics and global procurement patterns, China's home market has maintained its position in steadying regional price trends. Market stability was strengthened by the balance between logistical structures and production capabilities.

Glucosamine Prices June 2024

During the second quarter of 2024, the glucosamine prices in the United States remained unsteady, chiefly driven by elevated domestic supply and subdued demand from sectors such as nutraceuticals and pharmaceutical. Additionally, lowered seasonal purchasing trend also influenced an unrelenting regressive pricing environment, further destabilizing market dynamics and prices. The quarter-ending priced was 7394 USD/MT.

In the second quarter of 2024, prices of glucosamine in China witnessed notable fluctuations. The prices mostly dropped, primarily due to lowered consumer confidence, heavy variations in seasonal demands and lessened inquiries from overseas markets. Moreover, the supply-demand disproportion further fueled the detrimental pricing trend, ending the quarter at 5124 USD/MT.

Glucosamine Prices March 2024

During the first quarter of 2024, the glucosamine prices in the United States witnessed significant price reduction, mainly due to fluctuating demand and oversupply. Local suppliers were compelled to adjust pricing due to supply chain disruptions at the United States ports. Elevated freight costs and ample supply further lowered the prices despite stable demand in the latter months, concluding the quarter at 7589 USD/MT.

Glucosamine Prices December 2023

The glucosamine prices in the United States saw notable price fluctuations in Q4 2023. Global trends, particularly in Asian countries, raised demand for glucosamine, creating an upward pressure on prices in the United States near the middle of the quarter. Unfortunately, the price collapsed to 8650 USD/MT, ending the quarter negatively due to increasing inflation and interest rates that negatively impacted consumer sentiment.

Glucosamine prices in China surged to 5670 USD/MT by the end of the 4th quarter of 2023. It was impacted by the strong product demand from the nutraceutical and pharmaceutical companies. Also, improving economic landscape in China and a rise in domestic and international offtakes contributed to the price increase.

Regional Coverage

The report provides a detailed analysis of the glucosamine market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the glucosamine price trend.

Global Glucosamine Price

The report offers a holistic view of the global glucosamine pricing trends in the form of glucosamine price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights the current price but also provides insights into glucosamine historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into glucosamine price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed glucosamine demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Glucosamine Price

Q3 2024:

During Q3 2024, the European market exhibited a unique stability, with Germany remaining the trading center and key market barometer for the region. With seasonal fluctuations typically occurring at this time of year, the quarter displayed strength and was right in line with solid market fundamentals in both halves. Market dynamics were bolstered by consistent demand patterns, coupled with well-balanced supply fundamentals. European distribution networks proved effective, especially through major German ports, allowing shipments to move despite the widespread supply chain issues that impeded tons of goods elsewhere, but Asian manufacturers were quick to put tight production scheduling around it, and China-based players remained rigid in enforcing their plans.

Q2 2024:

In the second quarter of 2024, glucosamine prices in Europe saw a significant decline, influenced by various factors. An overabundance of glucosamine stock reserves, particularly from key Asian exporters, resulted in a heightened pricing contention. This was further fueled by decreasing demand in crucial sectors such as pharmaceutical and nutraceutical and moderating of disruption in global trade, which caused a drop in freight costs and enhanced supply chain situations. Moreover, Germany constantly witnessed pressure from seasonal instability in joint health supplements demand and elevated stock levels, boosting the overall unfavorable market sentiment.

Q1 2024:

In the first quarter of 2024, glucosamine prices in Europe, especially in Germany, witnessed a stable downturn in prices. The market underwent substantial challenges, such as unstable energy costs, setbacks in supply chains, and the impact of escalated interest rates, which ultimately resulted in a volatile landscape. Costs of import from China were significantly affected by the country’s new year and Red Sea disruptions, further aggravating the market sentiment. In addition, the value reduction of Euro against US Dollar fueled the financial burden of Germany-based importers, spurring the subdued pressure on price trend.

Q4 2023:

The last quarter of 2023 had a mixed trend for the glucosamine market in the European region. As there was a large supply of products and a high product supply at first, the market encountered several difficulties. However, December saw a surge in pricing as a result of rising Chinese prices and heightened product demand in Germany.

This analysis can be extended to include detailed glucosamine price information for a comprehensive list of countries.

North America Glucosamine Price

Q3 2024:

In the third quarter of 2024, the North American glucosamine market showed stability. A consistent market support was provided by steady consumption trends from the domestic pharmaceutical and nutraceutical industries, and supply-side equilibrium was preserved by well-managed logistics. Despite persistent operational difficulties, such as shipping costs, distribution network complexity, and maritime congestion, the market demonstrated consistent performance. Balanced price levels in China's market, a major supplier of glucosamine, further strengthened the stability and kept the American nutraceutical industry in balance.

Q2 2024:

During Q2 2024, glucosamine prices in North America continuously decreased due an excess supply, mainly driven by excess supply in the regional market and challenging pricing from Asia-based suppliers. Heightening freight costs and disturbances in trading also complexed imports, prompting regional traders to minimize profits. Such supply chain obstacles led to a lowered inventories and declining demand. Seasonal purchasing patterns also promoted the regressive pricing trend, with diminished demand across industries like nutraceutical and pharmaceutical, worsening the situation.

Q1 2024:

In Q1 2024, the glucosamine market in North America experienced a substantial decrease in prices, mainly impacted by profuse availability, unstable demand, and elevating freight costs. In addition, supply chain disruptions, mainly due to overload at the United States ports and Red Sea security issues, further downturned the prices. Despite projections for post-holiday rebound, demand did not accelerate as expected. Consequently, the local suppliers in the United States were prompted to adjust their pricing approaches, resulting in lowered profit margins amid an excess inventory situation.

Q4 2023:

The North American glucosamine market witnessed a blend of negative and positive price trends in Q4 2023. These mixed trends were caused by fluctuating demand from downstream sectors, surplus product inventory, and declining consumer trust because of escalating interest rates. Beyond this, the global trends, particularly in Asia, impacted market sentiment and price trends in North America.

Specific glucosamine historical data within the United States and Canada can also be provided.

Middle East and Africa Glucosamine Price

The report explores the glucosamine pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on glucosamine prices for countries can also be provided.

Asia Pacific Glucosamine Price

Q3 2024:

In Q3 2024, the Asia-Pacific glucosamine market was characterized by stable market circumstances and consistent pricing trends. Balanced operational variables and market fundamentals served as the foundation for this market stability. Despite continuous operational considerations, supply elements stayed stable, and demand patterns demonstrated persistent procurement from the pharmaceutical and nutraceutical sectors, both domestically and internationally. Throughout the quarter, supply-demand equilibrium was maintained by the balance between manufacturing capacity and logistical frameworks. Predictable order patterns and frequent buyer contact demonstrated market consistency. Together with controlled operational elements like freight costs, these stable demand indicators allowed industry players to keep margins steady.

Q2 2024:

During Q2 2024, Asia Pacific region experienced pronounced challenges, highlighted by a consistent decrease in prices. The overabundance of glucosamine, alongside subdued demand from international as well as domestic markets, prompted producers to lower output and employ dynamic pricing strategies to clear stock reserve. In addition, escalated freight costs and disturbances in logistics further aggravated the market inconsistency. Resultantly, the region witnessed a constant fall in prices, highlighting the ongoing complexities in harmonizing supply with demand and controlling the difficulties of the distribution system.

Q1 2024:

In Q1 2024, glucosamine prices in the Asia Pacific region underwent notable challenges, with China witnessing a significant influence. The market experienced a substantial drop in prices, principally driven by a contraction in demand from overseas as well as domestic buyers, predominantly in nutraceutical and pharmaceutical industries. This demand-supply disparity compelled market players to lower prices. Moreover, dormant purchasing activities in downstream industries, along with inconsistent costs of raw material and amplified stock reserves, contributed to the depreciating pressure on price trends.

Q4 2023:

In Asia Pacific, the price of glucosamine witnessed an optimistic trend during the final quarter of 2023. This is attributed to increased demand from end-user industries that were experiencing robust growth due to favorable economic conditions and elevated new business inflows. Also, the new inquiries from international markets further contributed to the positive price trends.

This glucosamine price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Glucosamine Price

The analysis of glucosamine prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Glucosamine Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Glucosamine Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2024 Edition,” offers an in-depth analysis of glucosamine pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of glucosamine at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of glucosamine price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing glucosamine price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Glucosamine Industry Analysis

The global glucosamine industry size reached US$ 899.5 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 1411.4 Million, at a projected CAGR of 5.10% during 2023-2032.

• The rising geriatric population across the globe suffering from age-related issues, such as osteoarthritis, is one of the primary drivers propelling the market growth. This prompts the use of glucosamine to treat and ease the symptoms of osteoarthritis. According to the Institute for Health Metrics and Evaluation, it is anticipated that by the year 2050, around 1 billion people will be living with osteoarthritis, while osteoarthritis of hand and knee will increase by 50% and 75%, respectively.
• The growing market expansion is also being fueled by a greater awareness of joint health. A common supplement among those looking to maintain their joint health and range of motion is glucosamine. According to a research article published in March 2023, 40.9% of the research participants were found to be aware regarding a joint health disorder osteoarthritis. Moreover, as per the latest study reports, approximately 70 million people in the United States are living with chronic joint disorders.
• The high incidence of obesity also has a significant effect on the need for glucosamine. According to the World Health Organization, as of 2024, more than 1 billion, approximately 1 in 8 people, are suffering with obesity globally.
• The growing popularity of wellness products is also fueling the glucosamine market's growth. The need for supplements that support and improve physical performance and recuperation, like glucosamine, has increased as people become more active. As per industry reports, global wellness market is anticipated to increase by 57% in 2027, reaching USD 8.5 trillion.

Glucosamine News

The report covers the latest developments, updates, and trends impacting the global glucosamine industry, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in glucosamine production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the glucosamine price trend.

Latest developments in the glucosamine industry:

• May 2023: Cargill, one of the major producers of glucosamine supplements, announced the development of a new plant that will be dedicated to produce mineral supplements particularly for cattle. The company has announced an investment of USD 20 million for this new facility construction.  
• November 2023: Jones Soda Co. expanded its product portfolio by entering into the pet segment and unveiled its new product Jones Craft Dog Soda, which contains human-grade functional supplement glucosamine to support both cartilage and joint health of the pets.

Product Description

Glucosamine is a natural sugar that exists in liquid form around the joints. This amino sugar is also used by the body to make other chemicals that build tendons, ligaments, and cartilage. It is available in the form of N-acetyl glucosamine, glucosamine hydrochloride, and glucosamine sulfate.

On the industrial scale, glucosamine is obtained from chitin, which is found in crabs, lobsters, and shrimp. There are several steps in the production process, such as raw material processing, chitin deacetylation, hydrolysis, purification, concentration, and packaging.

Glucosamine is used to treat osteoarthritis, glaucoma, joint pain, jaw pain, interstitial cystitis, and multiple sclerosis. It inhibits the onset of joint issues, encourages normal bone formation, lowers inflammation, and helps the body produce more cartilage and fluids around joints.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of glucosamine pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting glucosamine price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The glucosamine price charts ensure our clients remain at the forefront of the industry.